Jim Long Joins Notal Vision as Chief Financial Officer

Former Managing Director for Empresario Partners and Interim CFO for MDLive

Life Science Partner has recruited Jim Long to serve as Notal Vision’s Chief Financial Officer. Notal Vision is a health technology company offering the first patient-activated, home-based monitoring system to prevent the progression of macular degeneration through early detection and intervention. As the CFO of Notal Vision, Long will report to Quinton Oswald, CEO, and will be responsible for overseeing all financial matters including fundraising to accelerate the company’s growth trajectory.

Long has extensive tenure in leading healthcare companies’ financial planning and operations along with notable successes in creating strategic partnerships for realigned the financial team culture and performance while partnering with the Board Chairs, Founders, and Senior Executives to bring key initiatives to fruition.  His financial leadership of several major company transitions is regarded as a key asset for his new role at Notal Vision.

“Having led multiple corporate sales requiring post-sale restructuring as the head financial officer, Long has the background in complex financing required to fund Notal Vision’s aggressive growth objectives,” states Tom Callaway, MD, President and Founding Partner of Life Science Partner.  “He will be an excellent partner with Quinton to build a highly valuable company.”

Long earned his Bachelor of Arts Degree in Economics and Spanish and his MBA in Finance and Accounting from The University of Texas at Austin.

 

Roni Amiel Joins Notal Vision as Chief Information Officer

Former Chief Information Officer, Pinscriptive

Life Science Partner has recruited Roni Amiel to serve as Notal Vision’s Chief Information Officer. Notal Vision is a health technology company offering the first patient-activated, home-based monitoring system to prevent the progression of macular degeneration through early detection and intervention.  In this new role, Amiel will lead the company’s health innovation technologies strategy, development, and implementation.

Amiel is well qualified for this innovative company’s leadership. As Co-Founder and CIO of Pinscriptive, Amiel built the company’s technology platform from the ground up integrating with payers, providers, and pharmaceutical companies.

Previously, Amiel served as the CIO for Blythedale Children’s Hospital where he led the implementation of enterprise information systems and technical services. Earlier in his career Amiel served in IT leadership roles for the City of New York’s Department of Health, Columbia University Medical Center’s Cardiovascular Research Foundation, and PTC Therapeutics. Amiel’s service in the Israeli Navy is an additional asset given Notal Vision’s R&D and production operations in Tel Aviv, as well as its Israeli investor base.

“Amiel is an entrepreneur at heart, with the information technology track record of building tools that improve patients’ lives,” states Tom Callaway, MD, President and Founding Partner at Life Science Partner. “He’ll thrive working with our client Quinton Oswald to build a first-to-market innovative solution to preserve the eyesight of patients with macular degeneration.”

Amiel earned his BS in Information Technology from Colorado Technical University and completed his MBA from Rutgers University.

Bert Slade, MD, Joins Tissue Tech as VP, Clinical Development

Former Chief Scientific and Medical Officer Advanced Wound Care, Smith & Nephew

Life Science Partner recruited Bert Slade, MD, to serve as the Vice President, Clinical Development for TissueTech.  Slade has built his career in leading clinical trials, medical affairs, and regulatory approvals for medical device and pharmaceutical companies worldwide.  He joins TissueTech while also providing clinical support for Chisholm Clinical Research Services where he has set up his own vehicle to conduct clinical trials using the European platform as an inroad to EU product approvals.

During his tenure at Smith and Nephew, Slade was challenged as the first CMO for the Advanced Wound Management Division to restructure the three-strategic business unit R&D Departments and two clinical groups into a single international R&D organization with the addition of post-marketing surveillance.

“With his extensive experience in FDA submissions of BLAs and NDAs including a clinical background in wound healing and regenerative medicine, Slade will serve as a critical asset for TissueTech’s clinical trial designs and submissions,” states Tom Callaway, President and Founding Partner of Life Science Partner.

Slade earned his Bachelor of Arts Degree in Biology from Hamilton College.  He earned his MD from the Upstate Medical Center at the University of New York.

Dave Driscoll Joins Avizia as Senior Vice President, Sales

Sales Leader at Visicue, Medsphere, Conifer Health, GE Centrocity, and Connecture

Life Science Partner has recruited Dave Driscoll to serve as Senior Vice President, Sales for Avizia. Avizia is an innovative telemedicine company providing an end-to-end telehealth platform that integrates care coordination software with industry-leading video devices and mobile apps, enabling clinics and hospitals to deliver quality patient care anywhere. In this new role, Driscoll will lead the expansion of Avizia’s sales program and executing strategies for the company’s continued growth.

As a seasoned sales leader with more than 25 years of experience driving significant top-line growth for multiple companies across the digital healthcare ecosystem, Driscoll is well-equipped to lead Avizia’s sales organization. Driscoll has a solid track record of leading solution-focused sales teams at enterprise software companies such as Visicu, Medsphere Systems, Conifer Health and GE Centricity.

“With and a wide network of strong relationships with integrated delivery networks, Driscoll will play an instrumental role in accelerating Avizia’s growth,” states Tom Callaway, MD, President and Founding Partner of Life Science Partner. “Avizia is the leader in the transformation of telemedicine, particularly in the new world of Accountable Care Organizations that need to link their primary care physicians and specialists.”

Driscoll earned his Bachelor of Business administration from Pennsylvania State University.

Brigham Briggs Joins Smiths Medical as VP, Global Sales Operations

Former Director, Global Sales Operations at Terumo BCT

Brigham Briggs has joined Smiths Medical as Vice President, Global Sales Operations – a newly created role for the company where Briggs will have responsibility over the sales organization worldwide. He will oversee the standardization of the sales pipeline, funnel management and incentive compensation across Smiths Medical’s sites around the globe.

Smiths Medical is a global manufacturer of specialty medical devices that provides innovative and lifesaving solutions for the hospital, emergency, home and specialist environments.

Briggs is well-equipped to lead Smiths’ sales operations after directing the worldwide sales operations, sales excellence, and Customer Centric Initiative for Terumo BCT, a medical device equipment manufacturer focused on blood processing technologies. Earlier, Briggs served as Executive Director, Commercial Operations for GreatBatch Medical where he led a global sales team driving business development, customer support, and revenue growth.

Earlier in his sales career Briggs served in sales leadership roles at American Medical System and Boston Scientific. Before joining the medical device industry, Briggs was a Captain for the US Air Force for Aircraft Maintenance and Logistics.

Briggs earned his Bachelor of Science Degree in Engineering from the United States Air Force Academy. He completed his Master of Science Degree in Logistics Management from the Air Force Institute of Technology and is Six Sigma Black Belt Certified.